Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sanofi-Aventis S.A. ADR (NQ: SNY ) 51.06 +0.44 (+0.87%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,560,797 Open 50.97 Bid (Size) 50.35 (1) Ask (Size) 51.30 (1) Prev. Close 50.62 Today's Range 50.87 - 51.27 52wk Range 42.63 - 55.72 Shares Outstanding 1,250,690,553 Dividend Yield 3.73% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally July 21, 2024 The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season. Via Benzinga European Commission Faces Court Criticism Over COVID Vaccine Contract Transparency Ahead Of Vote on Ursula Von Der Leyen's Reappointment July 17, 2024 European Commission faces scrutiny over COVID vaccine contract transparency ahead of key vote. Legal challenges and implications discussed. Via Benzinga Exposures COVID-19 Performance YTD +2.12% +2.12% 1 Month +8.16% +8.16% 3 Month +8.29% +8.29% 6 Month +0.45% +0.45% 1 Year -5.30% -5.30% More News Read More Stable Blue-Chip Stocks to Buy Before Earnings Season July 17, 2024 Via InvestorPlace Senate To Review Novo Nordisk's Levemir Insulin Discontinuation July 16, 2024 Via Benzinga Sanofi's $20B Consumer Health Unit Sale: Goldman Sachs, Morgan Stanley Line Up $6.5B Financing July 12, 2024 Via Benzinga Bernie Sanders Targets High Prices of Ozempic and Wegovy In US July 11, 2024 Via Benzinga EXCLUSIVE: VeeCon 2024 Announces Danica Patrick, Jerome Bettis, Paul Scheer, Mike Posner, Liquid Death CEO Mike Cessario As New Speakers July 11, 2024 Via Benzinga 3 Stocks to Sell Immediately Based on the French Election Results July 09, 2024 Via InvestorPlace What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients July 05, 2024 Via Investor's Business Daily Upcoming Stock Spinoffs: Should You Pounce or Pass? July 04, 2024 Via InvestorPlace 7 Safe Haven Stocks to Buy Before the Next Market Correction July 03, 2024 Via InvestorPlace Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data July 03, 2024 Via Benzinga Exposures Product Safety Novavax’s Second Act: How a Fallen COVID Star Could Rise from the Ashes July 03, 2024 Via InvestorPlace Exposures COVID-19 Heartburn Drug Zantac Litigation: GSK And Other Pharma Giants Face Trial Over Cancer Claims July 02, 2024 Via Benzinga Topics Lawsuit Exposures Financial Legal Surprise! 3 Stocks That Are Outperforming Nvidia in 2024. July 01, 2024 Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant July 01, 2024 Via Benzinga Where Will Novavax Be in 1 Year? June 29, 2024 Via The Motley Fool First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product June 27, 2024 Via Benzinga Exposures Product Safety Why Is Vigil Neuroscience (VIGL) Stock Up 32% Today? June 27, 2024 Via InvestorPlace Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine June 26, 2024 From Regeneron Pharmaceuticals, Inc. Via GlobeNewswire Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC June 26, 2024 Via Benzinga Industry Groups Back GSK's Effort To Halt 70,000 Lawsuits Associated With Heartburn Drug Zantac Caused Cancer June 20, 2024 Via Benzinga Topics Lawsuit Exposures Financial Legal Is It Too Late to Buy Novavax Stock? June 14, 2024 Via The Motley Fool Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks June 13, 2024 Via Investor's Business Daily Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club June 12, 2024 Via Investor's Business Daily Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
